We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$68.3M
AUM Growth
–
Cap. Flow
+$61.3M
Cap. Flow %
89.65%
Top 10 Hldgs %
62.8%
Holding
44
New
40
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$8.35M
2
NVDQ
Novadaq Technologies Inc.
NVDQ
+$5.92M
3
PLX icon
Protalix BioTherapeutics
PLX
+$4.61M
4
ATRC icon
AtriCure
ATRC
+$4.16M
5
PODD icon
Insulet
PODD
+$3.54M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 60.9%
2 Financials 1.22%
3 Communication Services 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$124B
$689K 1.01%
+8,600
New +$633K
EXAC
27
DELISTED
Exactech Inc
EXAC
$664K 0.97%
+33,636
New +$633K
SRGA
28
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$628K 0.92%
+5,569
New +$681K
UPI
29
DELISTED
UROPLASTY INC-NEW
UPI
$599K 0.88%
+289,332
New +$663K
ANAC
30
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$598K 0.88%
+106,993
New +$648K
KERX
31
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$575K 0.84%
+77,000
New +$602K
KBIO
32
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$452K 0.66%
+9,979
New +$452K
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$448K 0.66%
+10,000
New +$342K
MASI
34
DELISTED
Masimo
MASI
$371K 0.54%
+17,500
New +$368K
STXS icon
35
Stereotaxis
STXS
$128M
$343K 0.5%
+303,466
New +$384K
TGX
36
DELISTED
THERAGENICS CORP
TGX
$333K 0.49%
+160,719
New +$288K
PTN
37
Palatin Technologies
PTN
$13.7M
$319K 0.47%
+412
New +$316K
GRMH
38
DELISTED
GRAYMARK HEALTHCARE INC COM STK NEW (OK)
GRMH
$146K 0.21%
+693,027
New +$146K
BGMS
39
Bio Green Med Solution Inc
BGMS
$4.94M
– –
0
– –
ADAT
40
DELISTED
AUTHENTIDATE HOLDING CORP COM STK (DE)
ADAT
$124K 0.18%
+15,785
New +$156K
STRR
41
DELISTED
Star Equity Holdings
STRR
$89K 0.13%
+733
New +$89.8K
1
2

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM

DAFNA Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for DAFNA Capital Management, which disclosed 44 positions worth $68.3M. Its ten largest holdings account for 63% of the portfolio.

Its largest position is PHARMACYCLICS INC: 102,128 shares worth $8.12M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, followed by Financials and Communication Services.

  • DAFNA Capital Management's largest Q2 2013 buy was PHARMACYCLICS INC: 102,128 shares worth $8.12M.
  • DAFNA Capital Management's ten largest holdings make up 63% of its $68.3M portfolio in Q2 2013.
  • DAFNA Capital Management disclosed 44 positions in Q2 2013, its first 13F filing on record.

Based on DAFNA Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.